Emmaus Life Sciences's total assets for Q2 2025 were $23.34M, an increase of 3.85% from the previous quarter. EMMA total liabilities were $79.05M for the fiscal quarter, a -2.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.